Exacerbation action plans for patients with COPD and comorbidities: a randomised controlled trial

This international randomised controlled trial evaluated whether COPD patients with comorbidities, trained in using patient-tailored multidisease exacerbation action plans, had fewer COPD exacerbation days than usual care (UC). COPD patients (Global Initiative for Chronic Obstructive Lung Disease (GOLD) classification II–IV) with ≥1 comorbidity (ischaemic heart disease, heart failure, diabetes, anxiety, depression) were randomised to a patient-tailored self-management intervention (n=102) or UC (n=99). Daily symptom diaries were completed for 12 months. The primary outcome "COPD exacerbation days per patient per year" was assessed using intention-to-treat analyses. No significant difference was observed in the number of COPD exacerbation days per patient per year (self-management: median 9.6 (interquartile range (IQR) 0.7–31.1); UC: median 15.6 (IQR 3.0–40.3); incidence rate ratio (IRR) 0.87 (95% CI 0.54; 1.39); p=0.546). There was a significantly shorter duration per COPD exacerbation for self-management (self-management: median 8.1 (IQR 4.8–10.1) days; UC: median 9.5 (IQR 7.0–15.1) days; p=0.021), with no between-group differences in the total number of respiratory hospitalisations (IRR 0.76 (95% CI 0.42; 1.35); p=0.348), but a lower probability of ≥1 for respiratory-related hospitalisation compared to UC (relative risk 0.55 (95% CI 0.35; 0.87); p=0.008). No between-group differences were observed in all-cause hospitalisati...
Source: European Respiratory Journal - Category: Respiratory Medicine Authors: Tags: COPD and smoking Original Articles: COPD Source Type: research

Related Links:

[This Day] Abuja -Over 5,000 persons have benefited from diabetes, hypertension, cervical and breast cancer free screening, which was facilitated by MITEDA Wellness Initiative, a nongovernmental organisation and in collaboration with the Lagos State government.
Source: AllAfrica News: Health and Medicine - Category: African Health Source Type: news
Authors: Sneh A, Pawan T, Randeep G, Anant M, Mani K, Hadda V, Madan K Abstract Few studies have tried to assess prognostic variables in chronic obstructive pulmonary disease (COPD) patients requiring mechanical ventilation (MV). We evaluated serum C reactive protein, (CRP) pre-albumin (PA) and transferrin (TR) levels in AE-COPD patients requiring MV as prognostic markers of in hospital mortality. 93 AE-COPD patients on MV were evaluated. Detailed clinical evaluation was done daily. Serum CRP &PA were measured on admission, 3rd, 8th and 16th day; TR was measured on admission, 8th and 16th day. Demographics, bas...
Source: COPD: Journal of Chronic Obstructive Pulmonary Disease - Category: Respiratory Medicine Tags: COPD Source Type: research
Source: International Journal of Tuberculosis and Lung Disease - Category: Respiratory Medicine Authors: Tags: ORIGINAL ARTICLES Source Type: research
Authors: Robino C, Compagnone CA, Pozzi F, Curto F, Chieregato A PMID: 31820877 [PubMed - as supplied by publisher]
Source: Minerva Anestesiologica - Category: Anesthesiology Tags: Minerva Anestesiol Source Type: research
This study will report the results of a series of descriptive and survival analyses compare an exposure of COPD in people over 40 years old (N=22,942) to predict the outcomes of: heart failure, depression, anxiety, coronary artery disease, diabetes, anemia, hypertension, ischemic heart disease, underweight, and osteoporosis while controlling for EHR status of: smoking, age, sex, and rurality. Results will be computed in March 2019. By the date of the ERS Congress 2019, we will be able to report the results of the aforementioned analyses, which will demonstrate the utility of using large EMR datasets to illustrate comorbid ...
Source: European Respiratory Journal - Category: Respiratory Medicine Authors: Tags: General practice and primary care Source Type: research
Conclusions: COPD women, as compared with men, had similar distribution of disease severity and more exacerbations, despite milder smoking history. Women had higher prevalence of anxiety, valvular disease, thyroid disease, but lower prevalence of ischemic heart and cerebral disease and neoplastic disease.
Source: European Respiratory Journal - Category: Respiratory Medicine Authors: Tags: Clinical Problems Source Type: research
ConclusionsIdentification of distinct comorbidity health pathways in HF could provide the evidence for individualised person-centred care that targets specific comorbidities and associated symptoms.
Source: PLoS Medicine - Category: Internal Medicine Authors: Source Type: research
This self-management (SM) trial evaluated tailored action plans for exacerbations of COPD and comorbid conditions in Australian and Dutch patients. Primary outcome analyses demonstrated a reduction in COPD exacerbation duration and respiratory-related hospitalisation rate. This abstract reports secondary study endpoints.COPD patients (≥ 40 years, GOLD II-IV) with ≥ 1 comorbidity (ischemic heart disease, chronic heart failure, diabetes mellitus, anxiety, depression) were randomised to a SM intervention including individualised exacerbation action plans for COPD and comorbidities (n=102) or usual care (n=99). Health st...
Source: European Respiratory Journal - Category: Respiratory Medicine Authors: Tags: Rehabilitation and Chronic Care Source Type: research
Conclusion: Comorbid disease was frequently recorded in this asthma population. All-cause mortality for the study population did not differ from the Swedish population overall, but a higher death rate due to pulmonary causes (mainly COPD) was seen among the asthma patients.Sponsor: AstraZeneca.
Source: European Respiratory Journal - Category: Respiratory Medicine Authors: Tags: 1.6 General Practice and Primary Care Source Type: research
ABSTRACT Objective: To assess and compare the prevalence of comorbidities and risk factors for cardiovascular disease (CVD) in COPD patients according to disease severity. Methods: The study included 25 patients with mild-to-moderate COPD (68% male; mean age, 65 ± 8 years; mean FEV1, 73 ± 15% of predicted) and 25 with severe-to-very severe COPD (males, 56%; mean age, 69 ± 9 years; mean FEV1, 40 ± 18% of predicted). Comorbidities were recorded on the basis of data obtained from medical charts and clinical evaluations. Comorbidities were registered on the basis of data obtained from medical charts...
Source: Jornal Brasileiro de Pneumologia - Category: Respiratory Medicine Source Type: research
More News: Anxiety | Cardiology | Chronic Obstructive Pulmonary | Depression | Diabetes | Endocrinology | Heart | Heart Disease | Heart Failure | Respiratory Medicine | Smokers